Background: in recent years, the role of positron emission tomography (PET) and PET/computed tomography (PET/CT) has emerged as a reliable diagnostic tool in a wide variety of pathological conditions. This review aims to collect and review PET criteria developed for interpretation and treatment response assessment in cases of non-[18F]fluorodeoxyglucose ([18F]FDG) imaging in oncology. Methods: A wide literature search of the PubMed/MEDLINE, Scopus and Google Scholar databases was made to find relevant published articles about non-[18F]FDG PET response criteria. Results: The comprehensive computer literature search revealed 183 articles. On reviewing the titles and abstracts, 149 articles were excluded because the reported data were not within the field of interest. Finally, 34 articles were selected and retrieved in full-text versions. Conclusions: available criteria are a promising tool for the interpretation of non-FDG PET scans, but also to assess the response to therapy and therefore to predict the prognosis. However, oriented clinical trials are needed to clearly evaluate their impact on patient management.
PET criteria by cancer type from imaging interpretation to treatment response assessment: beyond FDG PET score / Dondi, Francesco; Lazzarato, Achille; Gorica, Joana; Guglielmo, Priscilla; Borgia, Francesca; Filice, Rossella; Vento, Antonio; Pacella, Sara; Camedda, Riccardo; Caracciolo, Matteo; De Feo, Maria Silvia; Mammucci, Paolo; Frantellizzi, Viviana; Ortolan, Naima; Fiasconaro, Elisa; Urso, Luca; Evangelista, Laura; Laudicella, Riccardo; Santo, Giulia. - In: LIFE. - ISSN 2075-1729. - 13:3(2023). [10.3390/life13030611]
PET criteria by cancer type from imaging interpretation to treatment response assessment: beyond FDG PET score
Gorica, Joana
;De Feo, Maria Silvia;Frantellizzi, Viviana;
2023
Abstract
Background: in recent years, the role of positron emission tomography (PET) and PET/computed tomography (PET/CT) has emerged as a reliable diagnostic tool in a wide variety of pathological conditions. This review aims to collect and review PET criteria developed for interpretation and treatment response assessment in cases of non-[18F]fluorodeoxyglucose ([18F]FDG) imaging in oncology. Methods: A wide literature search of the PubMed/MEDLINE, Scopus and Google Scholar databases was made to find relevant published articles about non-[18F]FDG PET response criteria. Results: The comprehensive computer literature search revealed 183 articles. On reviewing the titles and abstracts, 149 articles were excluded because the reported data were not within the field of interest. Finally, 34 articles were selected and retrieved in full-text versions. Conclusions: available criteria are a promising tool for the interpretation of non-FDG PET scans, but also to assess the response to therapy and therefore to predict the prognosis. However, oriented clinical trials are needed to clearly evaluate their impact on patient management.| File | Dimensione | Formato | |
|---|---|---|---|
|
Dondi_PET-Criteria_2023.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
587.39 kB
Formato
Adobe PDF
|
587.39 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
